Triiodothyronine increases myocardial function and pyruvate entry into the citric acid cycle after reperfusion in a model of infant cardiopulmonary bypass

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 5, 2012, Pages

  Olson, Aaron K ^a,b   Bouchard, Bertrand ^d   Ning, Xue Han ^b   Isern, Nancy ^c   des Rosiers, Christine ^d   Portman, Michael A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Metabolism; Pediatrics; Reperfusion

Indexed keywords

AMINO ACID; LIOTHYRONINE; PYRUVATE SODIUM; PYRUVIC ACID C 13; THYROID HORMONE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CARDIOPULMONARY BYPASS; CITRIC ACID CYCLE; CONTROLLED STUDY; DECARBOXYLATION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HORMONE DETERMINATION; LIQUID CHROMATOGRAPHY; NEWBORN; NONHUMAN; OXYGEN CONSUMPTION; PIGLET; PRIORITY JOURNAL; REPERFUSION; STERNOTOMY; SUPPLEMENTATION; VAPORIZER;

ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID; CARDIAC OUTPUT; CARDIOPULMONARY BYPASS; CITRIC ACID CYCLE; DECARBOXYLATION; HEART; HYPOTHERMIA, INDUCED; MALE; MODELS, ANIMAL; MYOCARDIAL REPERFUSION; MYOCARDIUM; OXYGEN CONSUMPTION; PYRUVIC ACID; SWINE; TRIIODOTHYRONINE;

EID: 84857269343     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00959.2011     Document Type: Article

References (32)

1. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 73: 661-670, 1990.
2. Bettendorf M, Schmidt KG, Tiefenbacher U, Grulich-Henn J, Heinrich UE, Schonberg DK. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 41: 375-379, 1997.
3. Bhargava M, Lei J, Ingbar DH. Nongenomic actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine. Focus on "L-thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase." Am J Physiol Cell Physiol 296: C977-C979, 2009.
4. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19: 102-112, 2005.
5. 13C labeling of citrate released by perfused rat hearts. J Biol Chem 272: 26117-26124, 1997.
6. Des Rosiers C, Labarthe F, Lloyd SG, Chatham JC. Cardiac anaplerosis in health and disease: food for thought. Cardiovasc Res 90: 210-219, 2011.
7. 13C-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. Metab Eng 6: 44-58, 2004.
8. Fahien LA, Davis JW, Laboy J. Interactions between pyruvate carboxylase and other mitochondrial enzymes. J Biol Chem 268: 17935-17942, 1993.
9. Hermann HP, Pieske B, Schwarzmuller E, Keul J, Just H, Hasenfuss G. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet 353: 1321-1323, 1999.
10. Hyyti OM, Ning XH, Buroker NE, Ge M, Portman MA. Thyroid hormone controls myocardial substrate metabolism through nuclear receptor- mediated and rapid posttranscriptional mechanisms. Am J Physiol Endocrinol Metab 290: E372-E379, 2006.
11. Johnson SA, Denton RM. Insulin stimulation of pyruvate dehydrogenase in adipocytes involves two distinct signalling pathways. Biochem J 369: 351-356, 2003.
12. 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons. Am J Physiol Heart Circ Physiol 286: H1461-H1470, 2004.
13. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 81: S2347-S2354, 2006.
14. Liu Q, Clanachan AS, Lopaschuk GD. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts. Am J Physiol Endocrinol Metab 275: E392-E399, 1998.
15. Okere IC, McElfresh TA, Brunengraber DZ, Martini W, Sterk JP, Huang H, Chandler MP, Brunengraber H, Stanley WC. Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion. J Appl Physiol 100: 76-82, 2006.
16. Olson AK, Hyyti OM, Cohen GA, Ning XH, Sadilek M, Isern N, Portman MA. Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion. Am J Physiol Heart Circ Physiol 295: H2315-H2320, 2008.
17. Orfali KA, Fryer LG, Holness MJ, Sugden MC. Interactive effects of insulin and triiodothyronine on pyruvate dehydrogenase kinase activity in cardiac myocytes. J Mol Cell Cardiol 27: 901-908, 1995.
18. Panchal AR, Comte B, Huang H, Dudar B, Roth B, Chandler M, Des Rosiers C, Brunengraber H, Stanley WC. Acute hibernation decreases myocardial pyruvate carboxylation and citrate release. Am J Physiol Heart Circ Physiol 281: H1613-H1620, 2001.
19. Panchal AR, Comte B, Huang H, Kerwin T, Darvish A, des Rosiers C, Brunengraber H, Stanley WC. Partitioning of pyruvate between oxidation and anaplerosis in swine hearts. Am J Physiol Heart Circ Physiol 279: H2390-H2398, 2000.
20. Pantos C, Mourouzis I, Saranteas T, Brozou V, Galanopoulos G, Kostopanagiotou G, Cokkinos DV. Acute T3 treatment protects the heart against ischemia-reperfusion injury via TRalpha1 receptor. Mol Cell Biochem 353: 235-241, 2011.
21. Plumpton K, Justo R, Haas N. Amiodarone for post-operative junctional ectopic tachycardia. Cardiol Young 15: 13-18, 2005.
22. Portman MA, Fearneyhough C, Ning XH, Duncan BW, Rosenthal GL, Lupinetti FM. Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 120: 604-608, 2000.
23. Portman MA, Slee A, Olson AK, Cohen G, Karl T, Tong E, Hastings L, Patel H, Reinhartz O, Mott AR, Mainwaring R, Linam J, Danzi S. Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation 122: S224-S233, 2010.
24. Priestman DA, Donald E, Holness MJ, Sugden MC. Different mechanisms underlie the long-term regulation of pyruvate dehydrogenase kinase (PDHK) by tri-iodothyronine in heart and liver. FEBS Lett 419: 55-57, 1997.
25. Ralphe JC, Bedell K, Segar JL, Scholz TD. Correlation between myocardial malate/aspartate shuttle activity and EAAT1 protein expression in hyper- and hypothyroidism. Am J Physiol Heart Circ Physiol 288: H2521-H2526, 2005.
26. Russell RR 3rd, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol Heart Circ Physiol 261: H1756-H1762, 1991.
27. Scholz TD, Koppenhafer SL. Reducing equivalent shuttles in developing porcine myocardium: enhanced capacity in the newborn heart. Pediatr Res 38: 221-227, 1995.
28. Scholz TD, TenEyck CJ, Schutte BC. Thyroid hormone regulation of the NADH shuttles in liver and cardiac mitochondria. J Mol Cell Cardiol 32: 1-10, 2000.
29. Sugden MC, Langdown ML, Harris RA, Holness MJ. Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply. Biochem J 352: 731-738, 2000.
30. Vincent G, Bouchard B, Khairallah M, Des Rosiers C. Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts. Am J Physiol Heart Circ Physiol 286: H257-H266, 2004.
31. 13C-substrates and ex vivo perfusion in the working mode. Mol Cell Biochem 242: 89-99, 2003.
32. White LT, O'Donnell JM, Griffin J, Lewandowski ED. Cytosolic redox state mediates postischemic response to pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol 277: H626-H634, 1999.